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1. Introduction 
Stroke refers to brain damage and dysfunction that occurs due to the obstruction of blood 
flow to brain tissue. Stroke is one of the leading causes of death and disability worldwide, 
accounting for 10% of all deaths (Grysiewicz et al., 2008; Donnan et al., 2008). Risk of stroke 
is affected by a number of modifiable and non-modifiable risk factors. Age is the primary 
non-modifiable risk factor, while modifiable risk factors include chronic hypertension, 
diabetes, smoking, cholesterol and lack of exercise (Simons et al., 1998; Knuiman & Vu, 1996; 
Iso et al., 1989; Wadley et al., 2007).  
Ischemic stroke, the rapid development of a neurological deficit due to the disruption of 
blood supply to a specific region of the brain, is the most common cause of stroke. Usually 
caused by the blockage of an artery or vein by an embolus or blood clot, an ischemic stroke 
is a major cerebrovascular trauma with a mortality rate of 25% after one month (Donnan et 
al., 2008; Hossmann, 2006). Ischemic strokes are differentiated from transient ischemic 
attacks by neurological symptoms lasting for more than 24 hours (Albers et al., 2002). Death 
and extent of disability due to ischemic stroke is largely defined by location of the occlusion 
and corresponding size and location of the infarct.  
Brain injury following ischemic stroke results from an “ischemic cascade” of pathological 
events triggered by reduced blood flow. Disturbed ion homeostasis, excitotoxity, elevation of 
intracellular calcium concentrations, peri-infarct depolarisations, free radical generation, lipid 
peroxidation and protein synthesis dysfunction are all triggered by reduced blood flow and 
contribute to necrotic and apoptotic processes in ischemic tissue and expansion of the infarct 
(Dirnagl et al., 1999 and Hossmann et al., 2006). Notably, necrotic cell death tends to be fast 
and irreversible in the core or infarct of the stroke area, where blood flow falls below ~20% of 
baseline perfusion and results in energy failure in resident neurons (Hossman, 2006). 
However, in “penumbral” regions surrounding the core, partial blood flow is maintained and 
tissue is considered functionally silent but structurally intact. Importantly, damage in the 
penumbra is reversible, though this reversibility is time-limited (Hakim, 1987). Because 
pathophysiology in the penumbra evolves over hours and days after ischemic onset, it is 
believed that early treatments that restore blood flow or reduce brain damage can reduce 
damage and improve outcome (Green, 2008). Although hundreds to thousands of prospective 
treatments to salvage ischemic tissue or halt the pathological ischemic cascade have been 
identified, few have successfully been translated to clinical practice (Ginsberg , 2008; Wahlgren 
& Ahmed, 2005). In fact, only thrombolytic drugs have thus far produced significant positive 
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results for stroke patients in clinical trials. Of the thrombolytic drugs, intravenous recombinant 
tissue plasminogen activator (rtPA) has proved effective in reducing mortality and disability 
associated with ischemic stroke (Wardlaw et al., 2000). When it is administered in selected 
patients with acute ischemic stroke within 4.5 h of symptom onset, rtPA is highly effective in 
reducing death and disability (Buchan & Kennedy, 2007; Toni et al., 2005 and Lansberg et al., 
2009; Clark et al., 1999). Clinically, relatively few patients are treated with rtPA, primarily 
because the therapeutic window is prohibitively short compared to the usual delays in stroke 
recognition and patient transport, triaging and neuroimaging (Kwan et al., 2004). Moreover, 
40% of patients with early treatment and indications of salvageable tissue still do not respond 
to rtPA (Kaur et al., 2004). For middle cerebral artery occlusion (MCAo)—the most common 
cause of focal ischemic stroke—rtPA treatment restores blood flow in only 25–30% of patients ( 
Kaur et al., 2004). 
2. Collateral blood flow and collateral therapeutics 
With a paucity of effective treatments for acute stroke, new approaches to neuroprotection 
or reperfusion are needed. One strategy currently under investigation to improve post-
stroke outcome is to increase blood supply to ischemic tissue via intracerebral collateral 
circulation. The collateral circulatory system is defined as the vascular network through 
which blood flow can be partially maintained after the primary vascular routes are blocked 
(Liebeskind, 2003). “Collateral therapeutics” attempt to harness these endogenous vascular 
redundancies to improve blood flow to at-risk tissue.  
Cerebral collaterals can be classified as veinous, primary or secondary. The venous collateral 
circulation is highly variable, and augments drainage of cerebral blood flow during primary 
venous occlusion (Liebeskind, 2003). Primary collaterals refer to short arterial segments in 
the Circle of Willis, while the secondary collaterals refer to the ophthalmic and 
leptomeningeal collaterals (Liebeskind, 2003). The Circle of Willis is a circular vascular 
structure situated on the base of the brain that creates redundancy in cerebral blood flow 
between the internal carotid arteries and vertebrobasilar system (Hendrikse et al., 2005). In 
the case of occlusion or stenosis in these feeding arteries, blood can flow through the Circle 
of Willis and maintain blood flow in regions downstream of the narrowing or occlusion 
(Cieślicki et al., 1997). Similarly, collateral flow through the ophthalmic artery can partially 
restore blood flow to the distal carotid in the case of severe internal carotid artery occlusion 
or stenosis (Henderson  et al., 2000; Reynolds et al., 2002). Leptomeningeal collaterals (or 
pial collaterals) are anastomatic connections between distal branches of the cerebral arteries 
found along the surface of the brain that permit blood flow from the territory of an 
unobstructed artery into the territory of an occluded artery(Liebeskind, 2005).  
In this chapter, we will review methods for imaging cerebral blood flow relevant to 
investigations of stroke collaterals and illustrate the important link between stroke outcome 
and collateral circulation. Our review will focus primarily on the leptomeningeal collaterals 
and will incorporate both clinical and pre-clincial studies exploring the relevance of collateral 
blood flow for stroke prognosis and the potential benefits of collateral therapeutics. 
3. Imaging collateral blood flow in clinical and pre-clinical settings 
In this section, we will briefly outline some of the methods used to image blood flow in the 
clinical and pre-clinical setting. To image collateral vessels, single vessel resolution is 
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required. While no ideal strategy to image collateral blood flow has been identified, a 
number of techniques have been employed in the clinic and in animal research to image 
cerebral collateral circulation and begin to define the anatomy, physiology, and significance 
of collateral circulation in stroke. Collateral circulation is an important predictor of infarct 
size (Angermaier et al., 2011; Bang et al., 2008 and Zhang et al., 2010), and accurate imaging 
approaches are essential to optimize its predictive value and to properly evaluate the 
benefits and mechanisms of collateral therapeutics.  
3.1 Collateral blood flow imaging in humans 
A number of direct and indirect methods can be used to image cerebral blood flow in the 
clinical setting. Indirect measurements of cerebral blood flow during stroke allow inferences 
about collateral perfusion of ischemic tissue. Techniques such as magnetic resonance (MR) 
perfusion imaging, computed tomography (CT) perfusion, xenon-enhanced CT, single-
photon emission CT, and positron-enhanced tomography can be used to measure cerebral 
blood flow and assess the collateral status (Liebeskind, 2003). However, the utility of these 
methods is somewhat limited since only indirect information about collaterals blood flow is 
attained (Liebeskind, 2003). Single vessel resolution permits a more direct assessment of 
collateral blood flow in stroke patients. Direct visualization of collateral vessels can be 
obtained using cerebral digital angiography, CT angiography, MR angiography, and 
transcranial Doppler sonography (TCD) (Liebeskind, 2003). Below we will briefly discuss 
these direct imaging techniques for collateral blood flow during stroke. 
3.1.1 Cerebral angiography 
Cerebral digital angiography involves injection of a contrast dye (typically via the femoral 
artery) during X-ray imaging. A series of radiographs are collected as the contrast agent 
spreads through the cerebral vasculature, yielding high-resolution images of cerebral blood 
flow. Digital subtraction angiography improves resolution of vasculature in bony structures 
such as the cranium by subtracting a “mask” image acquired without contrast.  
Conventional angiography is the “gold standard” for observing cerebral blood vessels and 
angiography during stroke has confirmed the importance of collateral blood flow in 
determining tissue fate (Bang et al., 2008). However, the various methods used to quantify 
cerebral collaterals have not been well validated. Moreover, conventional angiography 
involves radiation exposure and is relatively invasive with a risk of complications including 
embolism, dissection, hematoma, allergic reaction to contrast dye, and nephropathy (Barlinn 
& Alexandrov, 2011; Hankey et al., 1990). Such complications are more common in older 
patients with atherosclerosis, a particularly relevant contraindication in the stroke 
population where both age and high cholesterol represent significant risk factors (Barlinn & 
Alexandrov, 2011, Simons et al., 1998; Knuiman & Vu, 1996; Iso et al., 1989).  
3.1.2 Magnetic resonance angiography 
Magnetic resonance angiography (MRA) uses MR imaging approaches to map blood vessels 
in the brain (Hartung et al., 2011). While there are several MRA variants, time-of-flight 
(TOF) MRA and contrast-enhanced (CE) MRA are most frequently used to image cerebral 
blood flow in patients with cerebrovascular disease (Barlinn & Alexandrov, 2011). Both 
techniques allow either 2-dimensional (2D) or 3-dimensional (3D) volume acquisition and 
are capable of detecting aneurysms, occlusions or stenosis in cerebral vasculature, with the 
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major differences being the requirement for a bolus injection of a contrast medium 
(gadolinium) for CE-MRA. Additionally, TOF-MRA permits higher-resolution images while 
CE-MRA allows faster collection over a larger anatomical volume, and reduced artefacts due 
to blood flow and vascular pulsation (Barlinn & Alexandrov, 2011; Hartung et al., 2011). 
Notably, MRA does not use ionization radiation, does not require an invasive catheter, and 
the “low-dose” contrast agent used with CE-MRA is considered less toxic than contrast 
media associated with conventional angiography. In fact, MRA techniques are considered 
the most powerful non-invasive methods to examine collateral circulation and 
hemodynamically relevant anatomical variations in Circle of Willis (Fürst et al., 1993). Still, 
MRA is not without limitations. Gadolinium based contrast agents have generally excellent 
safety profiles, but recent reports suggest a link to nephrogenic systemic fibrosis in patients 
with impaired kidney function (Weinreb & Abu-Alfa, 2009). Moreover, some stroke patients 
cannot tolerate or cooperate with the requirements for MRA, leading to movement artefacts, 
and MR cannot be used in patients with pacemakers or other magnetic appliances (Barlinn 
& Alexandrov, 2011). 
3.1.3 Computed tomography angiography 
Because it is widely available and well-tolerated by most stroke patients (Barlinn & 
Alexandrov, 2011), computed tomography angiography (CTA) is the most commonly used 
tool for diagnostic vascular imaging in the clinical stroke setting (Schellinger, 2005). A single 
bolus of iodine injected intravenously permits fast acquisition of high-resolution, thin slice 
CT images of cerebral vasculature. With proper post-acquisition processing, CTA images are 
comparable to DSA and allow 3D resolution of brain vasculature. With respect to stroke, 
CTA is very effective in detecting proximal arterial occlusions, allowing for differentiation 
between complete and near-occlusions, and stenoses, and provides information to predict 
functional outcome and response to thrombolysis. While CTA results in fewer motion 
artefacts than MRA, it requires radiation exposure and the toxicity and dose-size of the 
iodine used as a contrast agent is greater than that of the gadolinium. Moreover, risk of 
radio-contrast nephropathy after CTA is a serious concern, particularly in patients with 
kidney disease or diabetes (Barlinn & Alexandrov, 2011). Such concerns are particularly 
important with multiple examinations that lead to larger cumulative doses of radiation and 
iodine.  
3.1.4 Transcranial Doppler sonography 
Transcranial Doppler ultrasonography (TCD) can be used to measure the velocity of blood 
flow and waveforms in intracranial blood vessels through spectral Doppler sampling over 
particular cerebral blood vessels. TCD is relatively quick, non-invasive and inexpensive 
method to measure blood flow in the brain that offers information complementary to MRA 
and CTA. By analysing frequency shifts caused by the velocity of moving particles in the 
cerebral blood vessels, TCD provides real-time information on cerebral blood flow and 
hemodynamics and can be used to monitor blood flow without exposing patients to 
repeated doses of radiation or contrast agents. TCD is limited in that it does not allow for 2D 
or 3D reconstruction of vascular networks in the brain, and is highly dependent on the 
experience and aptitude of the sonographer (Barlinn & Alexandrov, 2011). While it is 
primarily used in human patients, a recent study using TCD in a rat model of middle 
cerebral artery occlusion identified a redistribution of blood flow after stroke (Li et al., 2010). 
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3.2 Imaging collateral blood flow in laboratory animals 
Due to the heterogeneity of the clinical population and differences in delay from onset, the 
availability of diagnostic imaging, and the varying treatment options in human stroke 
patients, interpretation of data on collateral blood flow from clinical imaging can be 
difficult. Recent advances in blood flow imaging in animal models of stroke provide new 
opportunities to study the dynamics, persistence, and importance of collateral blood flow 
and the mechanisms and efficacy of collateral therapeutics in pre-clinical studies. Below we 
will discuss two methods for imaging single-vessel blood flow in animal models of stroke: 
laser speckle contrast imaging and two-photon laser scanning microscopy.  
 
 
Fig. 1. LSCI of dynamic leptomeningeal collaterals during acute stroke. A, LSCI image 
showing blood flow in the surface veins (V) and branches of the middle cerebral artery 
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(MCA) over the hindlimb and forelimb sensorimotor cortex. Note the blood flow through 
anastomatic connections between the distal segments of the ACA and MCA immediately 
after MCAo (arrows). B, Left and middle panels show blood flow prior to and 
immediately after MCAo mapped with LSCI, while the right panel shows blood flow 24 
hours after stroke. Spontaneous reperfusion occurred between imaging sessions and 
blood flow through anastomatic connections ceased by 24 h (large arrows). Darker veins 
indicative of increased veinous blood flow from the territory of the MCA were observed 
after reperfusion (asterisks). C, Left, midle and right panels show LSCI blood flow maps 
before, after, and 24 hours after MCAo. Arrows indicate new patterns of collateral flow 
through anastomatic connections between the ACA and MCA that were apparent soon 
after MCAo and persisted at 24 h after onset. The small arrow identifies an anastamose 
with blood flow 24 h after MCAo that was not apparent immediately after onset. A, 
anterior; P, posterior; M, medial; L, lateral. Figure from Armitage et al., 2010 (used with 
perimission).  
3.2.1 Laser speckle contrast imaging (LSCI) 
LSCI is a technique that allows high spatial and temporal resolution during full-field 
imaging of changes in blood flow on the surface of the brain. Requiring only inexpensive 
instrumentation and simple analysis, LSCI provides resolution to individual blood vessels 
and is extremely effective in mapping changes in collateral blood flow during stroke 
(Armitage et al., 2010). LSCI maps of blood flow are based on blurring of the characteristic 
laser speckle pattern produced by illumination of the brain surface (or skull) with coherent 
laser light. Importantly, the speckle pattern is dynamic and blurred by moving particles 
(such as blood cells) on or below the illuminated surface. By analyzing fluctuations in the 
speckle pattern in a particular image, speckle contrast values that provide a measure of 
relative changes in blood flow can be calculated. The speckle contrast factor (K) is a measure 
of the local spatial contrast of the laser speckle pattern and is defined as the ratio of the 
standard deviation to the mean intensity (K = σs/I) in a small region of the speckle image 
(typically 5× 5 or 7 x 7 pixels). Speckle contrast and motion of the scattering particles are 
inversely related. K values ranges from 0 to 1, with values near 1 suggesting no blood flow 
in that vessel and values closer to zero reflect greater blood flow. By plotting K values, LSCI 
allows for maps of blood flow and can reveal changes in the pattern of blood flow after focal 
ischemia, including enhanced collateral perfusion or spontaneous reperfusion. LSCI has 
been used in animal models after middle cerebral artery occlusion (MCAo) to measure 
cerebral blood flow changes after stroke (Figure 1, Armitage et al., 2010; Dunn et al., 2001; 
Shin et al., 2008; Strong et al., 2008 ).  
While LSCI permits sensitive mapping of blood flow in surface vessels, the exact 
quantitative relationship between speckle contrast and blood flow velocity remains 
undefined (Duncan & Kirkpatrick, 2008). LSCI is susceptible to experimental artifacts that 
can vary between animals and imaging sessions (Parthasarathy et al., 2008; Ayata et al., 
2004) and is best restricted to describing relative changes in the pattern of blood flow rather 
than quantifying blood flow velocity (Parthasarathy et al., 2008; Ayata et al., 2004).  
3.2.2 Two photon laser scanning microscopy (TPLSM) 
TPLSM permits visualization of fluorescent molecules up to 1 mm below the surface in 
opaque tissues such as brain. During single photon fluorescence microscopy, short 
excitation wavelengths prevent deep penetration into tissues and increase light 
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scattering and phototoxicity (Helmchen & Denk, 2005; Svoboda & Yasuda, 2006 and 
Mulligan & MacVicar, 2007). Because it uses “pulse lasers” that facilitate multiphoton 
excitation of fluorophores, TPLSM allows the use of longer excitation wavelengths. In 
addition to improving penetration into the tissue, these wavelengths have lower 
phototoxicity. Moreover, multiphoton excitation will only occur in the focal volume of 
the objective, meaning that all fluorescence collected arises from fluorophores in the 
focal plane, allowing for optical sectioning and 3D reconstructions of flourophore 
distribution. TPLSM has previously been used to demonstrate that stroke induces a rapid 
loss of this dendritic microstructure in individual neurons (Zhang et al., 2005; Zhang & 
Murphy, 2007). Importantly, synapses can be restored even after delayed reperfusion  
(Li & Murphy, 2008) and long-term recovery is associated with enhanced synaptogenesis 
beside the stroke core (Brown & Murphy, 2008; Brown et al., 2007; Brown et al., 2009), 
suggesting that methods to facilitate synapse preservation during acute stroke or spine 
formation during recovery may be of functional benefit. In vivo calcium imaging using 
TPLSM also demonstrated functional rewiring of sensorimotor neurons as new regions 
of the cortex adopt the function of tissue lost to stroke (Winship & Murphy, 2008; 
Winship & Murphy, 2009).  
TPLSM has been important in defining the rules governing cerebral blood flow (Zhang & 
Murphy 2007; Shih et al., 2009; Takano et al., 2006; Nishimura et al., 2010; Mulligan & 
MacVicar, 2004). Cortical microcirculation can be precisely measured in vivo during TPLSM 
after blood plasma is labelled with a fluorescent-conjugated dextran (Figure 2). This technique 
permits resolution of blood flow in veins and arteries on the brain surface as well as arterioles 
and capillaries in the microvascular bed below the surface of the cortex. Moreover, it allows for 
precise quantification of the direction and speed of motion of blood cells in these vessels, 
something that is not possible with LSCI. After stroke, TPLSM can identify vessels at the 
capillary level that were not previously carrying blood (Schaffer et al., 2006 and Shih et al., 
2009). Red blood cell velocity can then be precisely measured in individual arterioles, veins, 
and capillaries in the penumbral cortex and three-dimensional reconstructions of the 
microvascular architecture and diameter of these vessels can be created.  
4. Collaterals and ischemia 
As noted previously, the collateral circulation is divided into three distinct pathways. 
Primary collateral circulation is particularly important after occlusion or stenosis of the 
brains major feeding arteries, the ICAs and the vertibrobasalar system. In patients with 
severe stenosis of the ICA, collateral flow through anterior and posterior communicating 
arteries and retrograde filling through the ophthalmic artery correlate with patient survival 
rate. Moreover, collateral flow is correlated with a lower risk of hemispheric stroke and 
transient ischemic attack (Henderson et al., 2000). After severe stenosis of the ICA, enhanced 
collateral flow through anterior Circle of Willis is observed and the diameter of the 
communicating arteries is increased (Hartkamp, 1999). Similarly, patients with bilateral ICA 
occusion exhibit significant collateral flow through the posterior Circle of Willis and 
increased posterior communicating artery diameters (Hartkamp, 1999). In fact, in patients 
with ICA occlusion, blood flow in the territory of the MCA ipsilateral to the occluded ICA is 
derived primarily from the vertebrobasilar arteries while ACA flow is mainly supplied by 
the contralateral ICA (Van Laar et al., 2007).  
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Fig. 2. Quantitative measurement of cerebral blood flow and vascular anatomy. A, B 
Photomicrographs of the surface of the mouse sensorimotor cortex. C, TPLSM of vasculature 
loaded with rhodamine dextran, showing surface arterioles and microvascular bed below 
the cortical surface. D, E, Quantitative measurement of blood cell velocity using line scans 
was made in the region denoted by the line in D. Resulting line scans are compiled in E, and 
by calculating the slope (time/ distance), a quantitative measure of blood flow velocity can 
be calculated. Using two channel imaging in mice expressing green fluorescent protein in 
subset of neurons, neuronal microstructure can be imaged simultaneously with cerebral 
blood flow (F). Images complements of Dr. Craig E. Brown, University of Victoria. 
4.1 Leptomeningeal collateral vasculature 
First described by Heubner in 1874, a leptomeningeal artery is described as a pial artery that 
connects two major cerebral arteries supplying distinct areas of the cerebral cortex (Heubner 
1874; Brozici et al., 2003). Similar to the primary collateral vascular system, it is thought that 
augmentation of the leptomeningeal collateral vascular system, by flow diversion from the 
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primary circulation, could lead to increased cerebral blood flow and decreased infarct 
volume after a focal ischemic stroke.  
During middle cerebral artery occlusion (MCAo), high-velocity blood flow in the anterior 
cerebral artery (ACA) or posterior cerebral artery (PCA) are indicative of flow diversion. 
In turn, increased blood flow in the ACA and PCA is a potential source of blood flow to 
leptomeningeal arteries and may improve perfusion in ischemic tissue downstream of the 
MCAo. Kim et al (2009) used transcranial doppler ultrasonography, in combination with 
angiography, to measure flow diversion and collateral flow in 51 patients suffering from 
middle cerebral artery stenosis. Dividing the patients into three groups based on severity 
of stenosis, they found that patients with less severe stenosis had lower amounts of 
leptomeningeal collateral circulation, while more severe stenosis correlated with 
increased leptomeningeal blood flow. These results correlated with flow diversion in the 
ACA and PCA that was identified in 47% of individuals and increased with the severity of 
stenosis.  
A recent mathematical model of post-stroke blood flow suggests that the leptomeningeal 
collateral vascular system can maintain approximately 15% of the normal cerebral blood 
flow during MCAo (Ursino & Gianessi, 2010). Although blood flow at 15% of normal is well 
below the limit to preserve cellular function, this same study suggests that over time, 
collaterals may be able to increase their luminal diameter by 50%, thereby preserving 
normal cellular function until full blood flow can be restored (Ursino & Gianessi, 2010).  
4.2 Clinical importance of leptomeningeal collaterals  
While CT, positron emission tomography, MR perfusion and TCD have all been used to 
assess leptomeningeal collateral blood flow in a variety of different disorders, the most 
effective single method to visualize leptomeningeal collateral blood flow in humans remains 
through angiographic assessment (Mori et al., 2009; Derdeyn et al., 1999; Thurley et al., 2009; 
Wu et al., 2008). However, a combination of multiple imaging modalities is ideal to gain a 
greater understanding of blood flow in the ischemic cortex (Bang et al., 2008; Wu et al., 2008; 
Kim et al., 2009). By combining these imaging approaches, leptomeningeal collaterals have 
been linked to positive outcome after stoke including decreased infarct volumes and 
decreased National Institute of Health Stroke Scale (NIHSS) scores (Christaforidis et al., 
2005; Miteff et al., 2009; Lima et al., 2010). 
While leptomeningeal collaterals are seen as a positive indicator of post stroke outcome, it is 
interesting to note that the presence of leptomeningeal collaterals in humans can indicate 
cerebrovascular impairment, the presence of vascular occlusive diseases, and are predictive 
of stoke in certain individuals. For example, Moyamoya disease is a chronic cerebrovascular 
disorder caused by progressive stenosis or occlusion of the internal carotid artery, leading to 
headaches, transient ischemic attacks and stroke (Robertson et al., 1997). Due to the long-
term occlusive nature of this disease, leptomeningeal arteries become highly developed and 
have been shown to be a positive indicator of severity of ischemic symptoms (Mori et al., 
2009), and are associated with engorged pial networks and slow blood flow (Chung & Park, 
2009). 
Yamauchi et al (2004) investigated the link between the patterns of collateral circulation and 
the types of infarcts. This study investigated 42 patients with symptomatic ICA occlusion 
using four-vessel angiography to assess Willsonian, ophthalmic, and leptomeningeal 
collaterals and MR imaging to measure infarct type and location. The study showed that the 
oxygen extraction fraction (a measure of the relative concentration of oxyhemoglobin and 
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deoxyhemoglobin that can be an indicator of a chronic ischemic condition) was significantly 
higher in patients with well developed ophthalmic or leptomeningeal collaterals and 
associated with the presence of striaocapsular infarcts, indicating that those with 
leptomeningeal and opthalmic collaterals were suffering from chronic cerebrovascular 
impairment. 
Although the presence of leptomeningeal collaterals are a positive indicator for future stroke 
risk, they are also associated with positive outcomes after stoke. For instance, in a 
retrospective angiographic study on collateral blood flow and clinical outcome after 
thromboembolic stroke, Christoforidis et al (2005), found that infarct volume and modified 
Rankin scale scores at discharge were significantly lower for patients with better 
angiographically-assessed lepotmeningeal collateral scores. This same study also found that, 
NIHSS score was significantly higher for patients with lower collateral scores. Similarly, 
Bang et al (2008) used MRI diffusion and perfusion in combination with angiographic 
assessment to measure collaterals in patients receiving recanalization therapy for acute 
cerebral ischemia. While this study found that diffusion-perfusion mismatch (a measure of 
penumbral or salvageable brain tissue) did not correlate with either good or poor collaterals, 
it showed that patients with good collaterals had larger areas with only mild hypoperfusion 
and infarct growth within the penumbra was smaller in these patients. Moreover, the study 
showed that patients with good pre-treatment collaterals more frequently had good 
recanalization and less infarct growth. Later studies confirmed that recanalization rate is 
heavily influenced by the collateral grade in patients undergoing endovascular 
revascularization therapy (Bang et al., 2011).  
Another study using angiographic assessment of collateral status in acute ischemic stroke 
demonstrated that major reperfusion was associated with good collateral status, and that 
good collateral status was significantly associated with reduced infarct expansion and more 
favorable outcomes (Miteff et al., 2009). Similar findings were also reported in a prospective 
cohort study by Lima et al (2010), which investigated patterns of leptomeningeal collateral 
blood flow by CTA and evaluated patient outcome after stroke. Lima et al. (2010) studied 
196 patients and found that a favourable pattern of leptomeningeal collaterals, along with 
younger age, lower baseline NIHSS, absence of diabetes and administration of rtPA, 
predicted improved outcomes 6 months after stroke. Additionally, Chistaforidis et al (2009) 
demonstrated that good collateral blood flow is linked to lower rates of hemorrhagic 
transformation. Of 104 patients who underwent intra-arterial thrombolysis, 25% of patients 
with poor leptomeningeal collaterals suffered significant hemorrhage, while only 2.78% of 
those with good collaterals suffered significant hemorrhage. Interestingly, this study also 
found that low platelet counts were predictive of significant hemorrhage, indicating that the 
administration of platelets after intra-arterial therapy may be beneficial. 
One explanation for improved patient outcome with increased leptomeningeal collateral 
circulation in stroke patients is due to the potential facilitation of recanalization and 
reperfusion. Currently, thrombolysis with rtPA is the most effective therapy for acute 
ischemic stroke. However, rtPA is ineffective in many patients who receive treatment within 
its short therapeutic window, particularly in the case of MCAo (Kaur et al., 2004). Part of 
this low success rate can be attributed to futile recanalization, defined as the lack of clinical 
benefit due to endovascular treatment of acute ischemic stroke even when recanalization is 
successful. Futile recanalization may be due to re-occlusion of the artery after initial 
thrombolysis or due to leptomeningeal collaterals that are insufficient to sustain tissue 
viability until recanalization occurs (Hussein et al., 2010; Liebeskind et al., 2008).  
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Good collateral status may also augment the effectiveness of neuroprotective drug therapies 
by providing increased routes for pharmacological agents such as rtPA to reach the ischemic 
penumbra and aid in recanalization. 
4.3 Animal models and leptomeningeal collaterals 
Clinical evidence strongly suggests that increased leptomeningeal collateral blood flow is a 
positive indicator for post stroke outcome. Moreover, it is thought that augmenting collateral 
blood flow via the leptomeningeal arteries by pharmacological or mechanical means may 
maintain blood supply in the ischemic penumbra and reduce cell death in this at-risk tissue. 
However, much about the dynamics of collateral blood flow during ischemic stroke remains 
unknown. As noted, clinical studies are limited by the access to imaging modalities and 
heterogeneity in treatment options and patient demographics. Animal models offer greater 
experimental control and facilitate an understanding of collateral vascular dynamics.  
When assessing collateral dynamics and therapeutics in animal models, it is important to 
consider strain differences in the number of collaterals before stroke. While animal studies 
have shown that collateral growth is enhanced in the weeks after stroke, and highly 
developed collateral blood flow prior to stroke is associated with decreased infarct size, 
estimation of the leptomeningeal collateral network size, a number that varies from birth, is 
difficult (Wei et al., 2001; Lin et al., 2002; Chalothorn et al., 2007; Zhang et al., 2010). In fact, 
Zhang et al (2010) investigated 16 different mouse strains to determine numbers of native 
collaterals. This study found statistically significant variation in collateral length, numbers 
of penetrating arterioles and infarct volume after middle cerebral artery occlusion. As 
expected, infarct volume correlated inversely with collateral number, diameter and number 
of penetrating arterioles (Zhang et al., 2010). As in human patients, the number and quality 
of collateral connections can vary greatly between individuals or animal strains, and is a 
predictor of stroke outcome. However, by examining collateral dynamics and the 
mechanisms and efficacy of collateral therapeutics in animal models with different collateral 
networks, inferences into the importance of leptomeningeal collateral blood flow after stroke 
can be made regardless of collateral density. 
Early studies in animal models focused on the regulation of leptomeningeal collateral blood 
flow. These studies showed that the pryriform branch of the MCA has collateral 
communication with the ACA, and that the parietal and temporal branches collateralize 
with the posterior cerebral artery after MCAo in Sprague-Dawley (SD) rats (Menzies et al., 
1993). After a MCAo or common carotid artery occlusion, leptomeningeal arterial blood 
pressure correlates with blood flow in ischemic areas and these arteries can further dilate to 
increase blood flow to the brain after stroke (Shima et al., 1983; Morita et al., 1997). Using 
laser doppler flowmetry in SD rats, Morita et al (1997) showed that pial arteries took ~12 s to 
become maximally dilated and around 131 seconds to become stable after common carotid 
artery occlusion. Although this rapid response is promising, it has been suggested that 
leptomeningeal collateral blood flow does not provide enough blood flow to maintain 
normal blood flow over a long time period (Derdeyn et al., 1998).  
In a recent study, LSCI was used to assess the dynamics and persistence of leptomeningeal 
collateral blood flow to ischemic territories over the 24 hours following thromboembolic 
MCAo in SD rats (Armitage et al., 2010). As shown in Figure 1, maps of blood flow revealed 
several (~ 3 - 6) anastomatic connections between the ACA and MCA that developed soon 
after vessel occlusion. Notably, these anastomoses were both persistent and dynamic: Blood 
flow through approximately 75% of these anastomoses persisted for at least 24 hours. The 
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anastomoses were dynamic during the imaging period: Blood flow through these collateral 
connections ceased after spontaneous reperfusion and, in some animals, collateral 
connections that were not apparent immediately after stroke were visible 24 hours post-
stroke. Importantly, in this study LSCI confirmed the persistence of blood flow though 
ACA-MCA anastomoses up to 24 hours after MCAo. However, more quantitative methods 
(such as TPLSM) will be necessary to better address the persistence of leptomeningeal 
collateral blood flow velocity as it relates to tissue viability.  
Changes in collateral flow in the first hours after stroke, including measures below the cortical 
surface, have been quantified using TPLSM. Importantly, TPLSM has confirmed flow reversal 
in distal sections of the MCA downstream from anastomoses with the ACA in a mouse model 
of transient MCAo (Murphy & Li, 2008). Overall, red blood cell velocity in arterioles 
downstream MCAo are reduced to 30% of baseline, and lumen diameters in small (< 23 µm 
diameter) surface arterioles and penetrating arterioles increased by approximately 20% (Shih 
et al., 2009) during acute ischemia. Importantly, this vasodilation persisted over 90 minutes of 
MCAo. Schaffer et al (2006) quantified blood flow reversals downstream of the occlusion and 
showed that approximately half of the arterioles downstream of the MCAo showed flow 
reversal, as would result from retrograde flow from the ACA into the territory of the MCA, 
within the two hours after occlusion. More recent studies suggest that these flow reversals are 
restricted to surface arterioles and do not persist to penetrating arterioles (Shih et al., 2009). 
Targeted occlusions of penetrating arterioles in the cortex have demonstrated that 
compensation is somewhat limited in penetrating vessels, as occlusion-induced dilations were 
restricted to vessels downstream of the occlusion and that neighbouring penetrating arterioles 
do not dilate to enhance collateral compensation (Nishimura et al., 2010).  
In addition to acute changes in collateral circulation, changes in leptomeningeal collaterals 
are observed after long-term recovery from MCAo. Coyle & Heistad (1987) demonstrated 
that normotensive Wistar Kyoto rats exhibited extreme collateralization (~27 anastamoses 
between the ACA and MCA) and little infarct one month after chronic MCAo. In fact, 
collateral vessels supplying blood to the MCA territory were able to restore blood flow to 
near baseline levels in the territory of the MCA one month after stroke. Contrasting this, 
stroke prone hypertensive rats (derived from a WKY background) exhibited the same 
number of anastomoses one month after stroke, but these connections were significantly 
narrower than WKY rats and hypertensive rats had significant infarction due to MCAo.  
5. Augmenting collateral blood flow during stroke 
Animal models and clinical data have clearly demonstrated the importance of collateral 
circulation during acute ischemic stroke in determining stroke prognosis and response to 
recanalization therapy. Based on these subsidiary vascular networks, it has also been 
suggested that enhancing collateral blood flow may reduce ischemia without targeting the 
clot. While therapies to enhance collateral flow such as adjusting head position, intravenous 
fluid support, and pressure augmentation have been suggested as neuroprotective 
strategies, collateral therapeutics remain a relatively unexploited neuroprotective strategy 
(Liebeskind 2003, 2005). In this section, we will explore different means of collateral blood 
flow augmentation and their efficacy in the treatment of acute ischemic stroke.  
5.1 Angiogenesis and collaterals 
A number of studies have highlighted the importance of angiogenesis in the development of 
collateral channels throughout the vascular system and their role in ischemia. Angiogenesis 
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is mediated by a number of angiogenic factors including vascular endothelial growth factor 
(VEGF), fibroblast growth factor (FGF), granulocyte colony stimulating factor (G-CSF) and 
angiopoietin (among others) and can be induced by circulating inflammatory cells during 
atherosclerosis (accounting for the increased collateral vasculature seen with chronic 
cerebrovascular insufficiencies) (Schirmer et al., 2009; Deb, 2010). After portal vein ligation, 
VEGF expression and collateral angiogenesis is upregulated, and inhibition of VEGF 
receptor-2 via a monoclonal antibody (DC101) or autophosphorylation (by SU5416) can 
decreases portal-systemic collateral density by up to 68% or 52%, respectively (Frenandez et 
al., 2004). In fact, VEGF expression appears to be critical for the formation of the collateral 
vasculature in many models of ischemia. In a mouse model of altered lipid metabolism, 
ApoE-/- deficient mice have reduced expression of VEGF and decreased hind limb vascular 
collateral development (Couffinhal et al., 1999). Strain differences in the expression of the 
vegfa gene account for a 54% difference in collateral remodelling after hind limb ischemia 
between BALB/C and C57BL/6 mice, as well as reduced collateral density in the intestine 
and cerebral cortex of BALB/C mice when compared to C57BL/6 mice. The influence of 
VEGF-A on collateral density has been directly related to models of cerebral ischemia, 
where it has been shown that transgenic mice that express low levels of VEGF form fewer 
leptomeningeal collaterals during the perinatal period and have increased infarct volume 
after MCAo when compared to mice expressing high levels of VEGF (Clayton et al., 2008).  
Hepatocyte growth factor (HGF) is another angiogenic growth factor which promotes the 
growth of endothelial cells. HGF has been shown to efficiently increase the number of 
collateral vessels and improved the blood flow after hindlimb ischemia in rabbits (Pyun et 
al., 2010).  
Perhaps the most promising data relating angiogenic compounds to improved stroke outcome 
relates to G-CSF and granulocyte monocyte colony stimulating factor (GM-CSF). GM-CSF 
stimulates angiogenesis by releasing growth factors from mobilised monocytes and 
macrophages. The importance of G-CSF and GM-CSF was first reported in heart and cerebral 
artery disease and they were more recently shown effective for treating cerebral ischemia 
(Buschmann et al., 2003). In fact, a number of groups have identified a neuroprotective role for 
G-CSF and GM-CSF administered before or after ischemia in rodent models (Todo et al., 2008; 
Nakagawa et al., 2006; Schäbitz et al., 2008), likely in part due to its upregulation of the 
formation of collateral vascular channels. Prophylactic injection of GM-CSF in rats for 6 weeks 
prior to bilateral common carotid artery occlusion has been shown to attenuate functional 
impairment of cerebrovascular reserve capacity and increase leptomeningeal collateral density 
(Schneider et al., 2007). A recent study demonstrated that five days of daily GM-CSF or G-CSF 
administered to C57/BL6 mice after unilateral occlusion of the common carotid artery also 
promoted leptomeningeal collateral growth and decreased infarct volume (Sugiyama et al., 
2011). A subset of these animals received MCAo seven days after common carotid occlusion. 
Of this subset, animals that were treated with G-CSF or GM-CSF had smaller infarcts and 
greater cerebral perfusion than untreated animals. Although promising, the feasibility of GM-
CSF injection has yet to be tested in humans. 
5.2 Vasodilation and collateral flow 
For the most part, attempts to improve cerebral blood flow during stroke using vasodilatory 
compounds have not been neuroprotective. This may be because ischemic vasculature is 
already fully dilated during stroke, and therefore only non-ischemic vasculature dilates, 
resulting in vascular stealing that is deleterious to ischemic tissue (Bremer et al., 1980 and 
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Kuwabara et al., 1995). Bath application of N-Methyl-D-aspartate (NMDA) has been shown 
to enhance blood flow to collateral dependent tissue in a canine model of MCAo 
independent of neuronal nitric oxide production (Robertson & Loftus 1998). As such, 
collateral vessels appear to be under additional vasodilatory influences that are yet to be 
determined. Defining these mechanisms may aid the development of therapies directed at 
augmenting flow through collateral vessels to reduce infarct size.  
5.3 Augmenting cerebral blood flow by inducing mild hypertension 
Perhaps the most obvious way to increase collateral blood flow is by inducing systemic 
hypertension through pharmacological agents or volume expansion. As cerebral 
autoregulation is impaired during stroke, changes in mean arterial blood pressure have a 
linear effect of cerebral blood flow. Similarly, decreasing the blood pressure in ischemic 
patients during acute stroke can exacerbate neurological deficits (Oliveira-Filho et al., 2003; 
Ahmed et al., 2000; Vlcek et al., 2003). Therefore, it is thought that by artificially inducing 
hypertension, global cerebral blood flow can be increased, enhancing flow through 
leptomeningeal collaterals and thereby preserving blood supply to the ischemic penumbra 
and protecting neuronal function therein (Wityk, 2007; Bogoslovsky et al., 2006). A 
neuroprotective role for mild induced hypertension has been confirmed in animal models. 
Shin et al (2008) used intravenous phenylepherine to increase blood pressure after MCAo. 
The mild hypertension induced by phenylephrine increased blood pressure and cerebral 
blood flow when injected either 10 or 60 minutes after occlusion (Shin et al., 2008). Treated 
rats displayed decreased infarct volume after stoke, and the authors hypothesized that this 
was due to increased perfusion of ischemic territories via leptomenigneal anastomoses 
between the posterior cerebral artery, ACA, and MCA (Shin et al., 2008). Similarly, 
hypertensive treatment with phenylephrine that increased blood pressure by 65mm Hg 
reduced infarct volume by 97% in rabbits after one hour of MCAo and 45% in rabbits 
subjected to two hours of MCAo (Smrcka et al., 1998). Increasing blood pressure through 
angiotensin was also demonstrated to increase the mean arterial pressure by 40-60% and 
reduce infarct volume after transient MCAo in rats (Chileuitt et al., 1996). While mild 
induced hypertension may be neuroprotective, it is important to note that chronic 
hypertension worsens stroke outcome (Aslanyan et al., 2003; Geeganage et al., 2011; Toyoda 
et al., 2009), possibly due to inhibition of collateral blood flow. In spontaneously 
hypertensive rats, compensatory growth of leptomeningeal collaterals in response to chronic 
cerebral hypoperfusion is impaired relative to normotensive rats, though this compensatory 
growth is restored by anti-hypertensive therapies (Omura-Matsuoka et al., 2011). 
Clinically, blood pressure is often elevated during MCAo and clinical trials have not 
demonstrated unequivocal beneficial results in neurological outcome after stroke 
(Liebeskind, 2003). Moreover, the risks of elevated blood pressure in stroke patients are not 
well defined, and hypertensive treatments may increase the risk of intracerebral 
hemorrhage, reflex bradycardia and possibly even ischemic bowel disease (Wityk, 2007).  
Still, preliminary data suggest some benefit. An increase in mean arterial pressure of at least 
10mm Hg (induced by norephenephrine administration) improved perfusion pressure in 
patients with MCAo with only a small increase in intracranial pressure (Schwarz et al., 
2002). Additionally, several preliminary studies have suggested that inducing mild 
hypertension may have functional benefits as measured by NIHSS scores and volume of 
hypoperfused tissue (Hillis et al., 2003; Rordorf et al., 2001). Induced hypertension may be 
particularly useful for patients ineligible for thrombolysis. In these patients, mild 
www.intechopen.com
 Understanding and Augmenting Collateral Blood Flow During Ischemic Stroke 
 
201 
hypertension induced via pheynylephrine increased mean arterial pressure by 20% resulted 
in a three point reduction on the NIHSS scale and moderate functional improvement on 
follow up measured using the Rankin scale (Bogoslovsky et al., 2006). 
5.4 Augmenting cerebral blood flow using partial aortic occlusion 
Another approach to facilitating reperfusion of ischemic territories is to increases global 
cerebral blood flow via temporary partial occlusion of the descending aorta. Using a 
catheter and balloon introduced via the femoral artery and inflated to occlude 70% of the 
suprarenal descending aorta, it is hoped that global cerebral perfusion and perfusion of 
ischemic territories by collateral pathways can be enhanced. Partial aortic occlusion has 
previously been shown to improve cerebral perfusion and neurological deficits in 
symptomatic vasospasm after subarachnoid hemorrhage (Lylyk et al., 2005), but its efficacy 
in ischemic stroke is unproven. Because many focal strokes are resistant to rtPA—
particularly MCAo—pilot studies are ongoing to assess the safety and efficacy of aortic 
occlusion treatment in animal models and stroke patients (Noor et al., 2009 and Shuaib et al., 
2011). In a non-ischemic porcine model, it was shown that partial occlusion of descending 
suprarenal aorta increased cerebral blood flow by 35-52% and that global cerebral perfusion 
remained elevated for 90 min after deflation (Hammer et al., 2009). Exciting preclinical data 
in a rat model of thromboembolic stroke supported a neuroprotective role for partial aortic 
occlusion, and demonstrated that aortic occlusion significantly reduces infarct volume at 24 
hours post-occlusion without increasing the risk of hemorrhagic transformation. Notably, 
treatment in combination with rtPA further reduced the infarct volume (Noor et al., 2009), 
suggesting a synergistic relationship between aortic occlusion and thrombolysis.  
Recently, the safety and efficacy of partial aortic occlusion was tested in patients up to 14 
hours after ischemic onset in the Safety and Efficacy of NeuroFlo in Acute Ischemic Stroke 
(SENTIS) trial (Shuaib et al., 2011). Importantly, the treatment appeared safe with no 
significant increase in adverse events as compared to standard stroke treatments. While 
overall efficacy was unclear, preliminary results suggest that aortic occlusion was effective 
in patients treated within 5 hours of onset, older than 70 years or age, and with moderate 
stroke severity. Moreover, partial aortic occlusion as an adjunct to thrombolysis appears 
safe, suggesting that studies of combination therapy are warranted (Emery et al., 2011).  
5.5 Augmenting cerebral blood flow with sphenopalatine and cervical spinal 
stimulation  
While partial aortic occlusion attempts to improve cerebral blood flow and reperfusion of 
ischemic territories by physically diverting blood from the periphery, other approaches 
attempt to manipulate the neurovascular interface to improve cerebral blood flow during 
stroke. One approach involves selective electrical stimulation of the parasympathetic nerves 
in the sphenopalatine ganglion. These fibres provide parasympathetic innervation of the 
anterior cerebral circulation, and a number of studies in animal models suggest that 
sphenopalatine stimulation elicits significant increases in cerebral blood flow (Ayajiki et al., 
2005; Suzuki et al., 1990; Yarnitsky et al., 2005). Recently, MR imaging and behavioural 
assessment was used to assess tissue characteristics and stroke recovery in MCAo rats after 
sphenopalatine ganglion stimulation treatment that began 18 hours after ischemic onset 
(Bar-Shir et al., 2010). Notably, n-acetyl-aspartate (NAA) levels (a marker of neuronal 
density and viability) were significantly greater in treated rats, and measures of neurological 
impairment at 8 and 28 days after stroke suggested a benefit of sphenopalatine ganglion 
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stimulation. Conversely, cutting the nerves eminating from the sphenopalatine ganglion 
increases infarct volume after MCAo (Diansan et al., 2010). Based on preliminary data, the 
safety of sphenopalatine ganglion stimulation is currently being evaluated in human stroke 
patients (Khurana et al., 2009).  
Spinal cord stimulation has been found effective in treating a number of disorders related to 
low cerebral blood flow (Robaina & Clavo, 2007). While it has not yet been tested in stroke 
patients, spinal cord stimulation in non-stroke patients significantly enhances blood flow in 
the common carotid and MCA (Robaina & Clavo, 2007). In rats, electrical stimulation of the 
cervical spinal cord increases cerebral blood flow (measured via laser Doppler flowmetry) by 
over 50% in control rats (Sagher et al., 2003). When initiated 20 minutes after MCAo, cervical 
spinal stimulation also improved blood flow in ischemic territories by over 30% (~64% 
reduction in blood flow prior to stimulation and ~30% below baseline after stimulation) and 
profoundly reduced infarct volume measured six hours after ischemic onset (Sagher et al., 
2003). Similarly, cervical spinal stimulation in cats significantly reduced infarct size 24 hours 
after stroke and mortality due to MCAo (Matsui & Hosobuchi, 1989). Based on these 
preliminary data, further studies in animal models and human patients are warranted.  
5.6 Augmenting cerebral blood flow using head positioning 
Cerebral blood flow to the brain can be augmented by supine positioning of head that 
results in increased arterial flow due to gravity. Importantly, this treatment can be applied 
as soon as an ischemic stroke patient is diagnosed. When head position is reduced from 30° 
to 0° elevation during the first 24 hours after ischemic onset, the mean flow velocity of MCA 
(measured using Transcranial Doppler) is increased by 20%, resulting in functional 
improvement in 15% of patients (NIHSS) (Wojner-Alexander, 2005). Conversely, a decrease 
in cerebral blood flow was observed by increasing the head position from 0° to 30° or 45° 
(Schwarz et al., 2002; Moraine et al., 2000), with cerebral blood flow determined according to 
the arteriovenous pressure gradient (Moraine et al., 2000). Applying a supine head 
positioning procedure may increase the intracranial pressure of some patients, and is 
therefore advisable when a higher perfusion rate is required even at the risk of increased 
intracranial pressure (Schwarz et al., 2002). More research is required, however, since it is 
not clear to what extent head position augments collateral blood flow, nor is it known how 
delay and duration of head positioning influence outcome.  
6. Summary 
Collateral circulation refers to subsidiary vascular networks in the brain whose 
pathophysiological recruitment can partially maintain blood flow when primary vascular 
routes are blocked. With respect to MCAo, clinical imaging suggests that blood flow 
through the leptomeningeal collaterals, anastomoses connecting the distal segments of the 
MCA to distal branches of the ACA, can partially restore blood flow to ischemic territories. 
Based on these subsidiary vascular networks, it has been suggested that enhancing collateral 
blood flow may reduce ischemia without targeting the clot. While therapies to enhance 
collateral flow remain relatively unexploited neuroprotective strategies, promising data 
from animal models and clinical evaluation suggest that collateral therapeutics offer a 
legitimate alternative and/or adjuvant to thrombolytic therapies. By furthering our 
understanding of the dynamics, persistence, and regulation of collateral blood flow and 
expanding on studies evaluating the mechanisms and efficacy of collateral therapeutics, 
improved strategies for stroke care can be developed.  
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